FBLG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price action is in a strong downtrend (SMA_200 > SMA_20 > SMA_5) with bearish momentum (MACD histogram negative and expanding).", "RSI is deeply oversold (RSI_6 ~19), which can support a short-term bounce, but there is no confirmation signal and no clear catalyst; for an impatient buyer this is still a low-quality entry.", "With no revenue and ongoing losses (2025/Q3), the tape is likely to remain sentiment-driven and fragile; best action is to stay on the sidelines unless a clear reversal/catalyst appears."]
["Trend: Bearish across timeframes (SMA_200 > SMA_20 > SMA_5), indicating sustained downside pressure.", "Momentum: MACD histogram at -0.0117 and negatively expanding => bearish momentum is strengthening, not stabilizing.", "Mean-reversion setup: RSI_6 at ~19.5 is oversold, so a bounce is possible, but oversold can persist in strong downtrends.", "Key levels: Pivot 0.33 overhead (major reclaim level). Near support S1 0.27 (price ~0.2647 post-market) with next support S2 0.233. Resistance levels: R1 0.39, R2 0.427.", "Short-horizon pattern odds: Similar-pattern projection suggests slightly negative next day (-0.78%) and next week (-0.23%), with only modestly positive next month (+1.2%), which is not compelling for an immediate entry.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
can trigger a reflex bounce if selling pressure eases.", "Post-market uptick (+5.84%) may indicate some dip-buying interest, though it is not a confirmed reversal."]
increases risk of a breakdown toward S2 (~0.
if support fails.", "No recent congress trading data available; no influential-figure flow signal to lean on.", "Hedge funds and insiders are neutral with no significant recent trends, offering no supportive positioning signal."]
["Latest quarter: 2025/Q3.", "Revenue: 0 (0.00% YoY) => no operating top-line traction showing up in reported financials.", "Net income: -5.778M (reported as 'up' YoY due to base effects), still a sizable loss.", "EPS: -0.13 (improved YoY by percentage, but remains negative).", "Overall: financial profile remains early-stage/weak with losses and no revenue, which typically limits sustained upside without a catalyst."]
["No analyst rating or price target change data provided; likely limited/low-visibility coverage.", "Wall Street-style pros: if any coverage exists, the main bull case would typically be optionality on future development progress rather than current fundamentals.", "Wall Street-style cons: lack of revenue, ongoing losses, and weak technical trend make it difficult to justify a buy based on conventional fundamental/technical criteria right now."]
